Nawaz Fouad 4
Research Summary
AI-generated summary
Exozymes (EXOZ) VP Finance Nawaz Fouad Receives 5,999-Share Award
What Happened
Nawaz Fouad, Vice President—Finance of Exozymes Inc. (EXOZ), was granted 5,999 shares on April 1, 2026. The transaction is reported as an award/acquisition (code A) at $8.44 per share for a total value of $50,632. This is an equity award (compensation-related acquisition) rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-04-01
- Transaction type: Award / Grant (SEC code A)
- Shares granted: 5,999 at $8.44 each — total value $50,632
- Shares owned after transaction: Not specified in the provided summary filing
- Filing date (accession): 2026-04-08 — the Form 4 was filed seven days after the transaction, which appears later than the usual two-business-day SEC filing requirement for Form 4s
- Footnotes/plans: No 10b5-1 plan, tax withholding, or other footnotes were noted in the provided transaction details
Context
Equity awards are typically compensation (e.g., restricted stock units or performance shares) and may vest over time; they do not carry the same immediate market-sentiment signal as an open-market purchase by an insider. There is no indication the shares were sold or immediately disposed of. Retail investors should view this as compensation-related issuance rather than a direct bullish purchase signal.